GlassScriptPhysician profile
Catherine D Cornish
NPI 1487662425
$1,313.41
in general payments reported to CMS, 2019-2025
14 companies · $622 in 2025
The $622 reported for 2025 was more than what 90% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.11 · 2022: $32.38 · 2023: $161 · 2024: $481 · 2025: $622.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,264.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $907.41 | 2023-2025 | Angiojet Ultra 5000a, Ranger, Innova Vascular |
| Organon LLC | $71.27 | 2022-2025 | Nexplanon |
| Gilead Sciences, INC. | $67.12 | 2023 | |
| Mayne Pharma Commercial LLC | $48.16 | 2025 | |
| Exeltis, USA INC. | $34.97 | 2024 | Slynd |
| Astellas Pharma US INC | $31.31 | 2025 | Veozah |
| Acella Pharmaceuticals, LLC | $23.81 | 2024 | NP Thyroid 60 |
| Exact Sciences Corporation | $21.94 | 2025 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $20.97 | 2025 | Aptima, Thinprep 2000 Processor |
| Millicent US INC | $20.91 | 2025 | Intrarosa, Femring |
| Sumitomo Pharma America, INC. | $19.39 | 2025 | Myfembree |
| Pfizer INC. | $16.43 | 2024 | |
| Merck Sharp & Dohme LLC | $16.11 | 2021 | |
| Minerva Surgical, INC | $13.61 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Cornish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.